Apyx Medical Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -123.2% | – | – | +23.9% | +43.1% | -92.1% | +459.0% | +394.3% | -109.3% | – | -31.6% | -63.6% | -113.2% | – | – | -91.3% | -1,637.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +19.4% | +153.0% | -59.2% | +23.6% | +32.1% | -47.6% | +14.5% | +25.6% | +38.2% | -3.0% | +45.6% | +26.2% | +7.9% | -4.2% | -8.1% | -7.4% | -3.5% | +5.9% | -7.3% | -9.6% | -5.2% | -3.9% | +12.7% | +17.6% | +1.8% | -1.4% | -22.2% | -13.4% | +9.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -25,747.2% | – | +19.5% | -19.0% | +22.0% | +214.3% | -23.3% | +48.2% | +40.7% | +7.7% | +75.1% | +134.8% | +17.6% | +20.9% | +31.6% | -23.6% | -21.5% | -50.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -73.4% | -95.7% | +103,191.7% | -108.6% | – | +12.9% | -5,812.2% | – | +41.8% | +7.4% | +27.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | -1,558.7% | – | – | – | – | – | – | -1,567.3% | – | +206.9% | -104.4% | – | – | – | – | – | – | – | – | -122.5% | – | |
| – | -43.6% | +24.6% | -60.5% | +102.1% | -32.5% | +27.6% | +156.5% | +7.2% | +50.1% | +171.9% | -30.8% | +164.0% | -45.5% | -91.8% | +169.7% | +38.9% | -21.9% | +7.1% | -33.2% | -32.1% | +118.2% | -41.8% | +258.4% | -55.3% | +24.4% | +39.7% | -47.2% | +35.5% | +54.3% | |
| – | -264.6% | +72.2% | -71.4% | +404.9% | -18.8% | -52.4% | +164.9% | -51.9% | +191.4% | +169.9% | -30.8% | +163.4% | -45.4% | – | -225.5% | +38.9% | -21.9% | +7.1% | +46.2% | -68.9% | +118.2% | – | +106.6% | -101.0% | +24.4% | +39.7% | – | -110.7% | +54.3% | |
| – | – | – | – | -64.2% | +20.4% | – | – | – | – | – | – | – | – | – | – | – | – | -102.3% | – | -55.0% | – | – | +2.5% | -28.5% | +31.8% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -96.6% | +24.6% | – | -107.9% | +0.6% | -0.6% | +1,405.0% | -97.8% | +515.0% | -35.5% | -37.8% | – | -100.1% | +0.0% | |
| – | – | +142.5% | -138.9% | -42.4% | -20.9% | -78.7% | – | +54.2% | -58.7% | +969.4% | -77.9% | +1,037.4% | -25.4% | -20.3% | -117.6% | -57.0% | – | -116.6% | – | -54.8% | -103.1% | +1,292.2% | – | -149.7% | – | +804.2% | +14,723.0% | -79.0% | +42.0% | |
| – | – | – | -40.8% | -200.0% | – | -166.4% | – | – | -150.3% | – | -64.9% | -266.8% | – | – | -37.0% | -168.2% | – | -158.2% | – | -56.3% | -270.0% | – | +628.1% | -140.0% | – | – | – | -135.6% | – | |
| – | – | – | – | -0.6% | +91.3% | -119.1% | – | – | -176.5% | – | -35.8% | -1,252.7% | – | – | – | -143.4% | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.